From: In vivo generation and regeneration of β cells in zebrafish
Inducer | Effects | Developmental stage | Cell source | Related mechanism | Modifer Screen | Gene/target identified | Related pathway | Reference | |
---|---|---|---|---|---|---|---|---|---|
Manipulation of Insulin signaling | Transgenic expression of a dominant-negative IGF1R | Insulin resistance | Embrynonic, Larval and adult | Progenitors and β cells | Proliferation | None | igf1r | Insulin signalling | (Maddison et al., 2015) |
Knockout of insra/insrb | Insulin resistance | Embryonic and larval | Unknown | N.A. | None | insra/insrb | Insulin signalling | (Yang et al., 2017) | |
Transgenic expression of a dominant-negative IRS2 | Insulin resistance | Embryonic | Progenitors | Neogenesis | None | irs2 | Insulin signalling | (Ye et al., 2016) | |
Nutrient | Increased insulin demand | larval | Progenitors | Neogenesis | Candidate drugs | fgf1/rapamycin | FGF, mTORC1 | ||
Nutrient | Increased insulin demand | Larval | Progenitors and β cells | Neogenesis | Candidate drugs | g secretase inhibitor and rapamycin | Notch, mTORC1 | (Ninov et al., 2013) | |
β-cell ablation | Decreased insulin supply | Larval | Progenitors and β cells | Neogenesis | Chemical library | Adenosine Receptor A2aa (agonist) | Adenosinergic | ||
β-cell ablation | Decreased insulin supply | Larval | β cells | Proliferation | Chemical library | TBK1/IKKε (inhibitor) | PKA, mTORC1 | (Xu et al., 2018) | |
β-cell ablation | Decreased insulin supply | Larval | Progenitors | Neogenesis | Mutation | Sox9b | Retinoic acid signaling; Notch signaling | ||
β-cell ablation | Decreased insulin supply | Larval | Progenitors | Neogenesis | Mutation | Dnmt1 | N.A. | (Anderson et al., 2009) | |
β-cell ablation | Decreased insulin supply | Larval | Progenitors | Neogenesis | Mutation | fhl1b | N.A. | (Xu et al., 2016) | |
β-cell ablation | Decreased insulin supply | Larval | α cells | Trandedifferentiation | Morpholino, antibody | gcg | non-gluconeogenic effects of glucagon | (Ye et al., 2015) | |
β-cell ablation | Decreased insulin supply | Larval | α cells | Trandedifferentiation | Mutation | Igfbp1 | IGF1 signaling | (Lu et al., 2016) | |
Chemical genetics | Chemicals | Inhibition or activation of drug targets | Larval | Progenitors | Neogenesis | None | ALDH1A1 (inhibitor), IMPDH (inhibitor) | RA, Nucleotide synthesis | |
Chemicals | Inhibition or activation of drug targets | Larval | Progenitors and β cells | Proliferation/ Neogenesis | None | NFkb activators, Serotonergic activators | NFkB, Serotonergic, glucorcorticoid analogs | ||
Chemicals | Inhibition or activation of drug targets | Larval | β cells | Proliferation | None | RXR agonists, serotonin boosters, GR agonists | RA, Serotonergic, glucocorticoid | (Tsuji et al., 2014) | |
Notch inhibition | Precocious β-cell differentiation | Larval | Progenitors | Neogenesis | Chemical library | CDK5 (inhibitor) | N.A. | (Liu et al., 2018) | |
Other | Microbiota | Unknown | Larval | Progenitors | Proliferation | larvae stage | BefA | N.A. | (Hill et al., 2016) |
CDK4 | Cell division activation | Larval | β cells | Proliferation | larvae stage | Cyclin-Dependent Kinase 4 | N.A. | (Li et al., 2013) | |
Genetic Lineage Tracing | Suppression of target gene | embryonic development | Acinar | Trandedifferentiation | None | Ptf1α | N.A. |